UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 16, 2008


IMMERSION CORPORATION
(Exact name of registrant as specified in its charter)
______________

Delaware

 

000-27969

 

94-3180138

(State or other jurisdiction of

incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

______________

801 Fox Lane

San Jose, California  95131

(Address of principal executive offices) (Zip Code)

______________

Registrant’s telephone number, including area code: (408) 467-1900


Not Applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 8.01     Other Events.

On April 16, 2008, Immersion Corporation ("Immersion") announced that its wholly owned subsidiary, Immersion Medical, Inc., filed a lawsuit for patent infringement in the United States District Court for the Eastern District of Texas against Mentice AB, Mentice SA, Simbionix USA Corp., and Simbionix Ltd.

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01     Financial Statements and Exhibits.

(d)  Exhibits

Exhibit

No.

  Description
99.1 Press release dated April 16, 2008 issued by Immersion Corporation



Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

IMMERSION CORPORATION

 

 

Date:

April 16, 2008

By:

/s/ Stephen M. Ambler

Stephen M. Ambler

Chief Financial Officer and Vice President,

Finance


Exhibit Index

Exhibit

No.

 

Description

99.1

Press release dated April 16, 2008 issued by Immersion Corporation